Updated : August 1, 2023

Department of Cancer Genomics and Medical Oncology

Members

Masayuki Takeda
Shunsuke Okazaki
Yumi Yoshii
Masahide Ota

Overview

We provide cross-organ chemotherapy for all solid tumors. With the advancement of medicine, many drugs such as molecular targeted drugs and immune checkpoint inhibitors have been introduced, and more advanced knowledge is required. In our department, we not only provide evidence-based treatment, but also manage side effects in close collaboration with other departments, pharmacists, and nurses. In the future, we will continue to develop new drugs, including unapproved drugs, and actively promote clinical trials of new drugs and combination therapy of approved drugs.

Website

Our website is here